Dr. Tadeu Vasconcelos used the ETHEREA-MX® platform, with the IPL-Sq® handpiece.
Treatment:
Localized scleroderma (LS) or morphea is a chronic connective tissue disease, of probable autoimmune etiology, that is based on alterations in collagen synthesis and deposition, represented clinically by sclerotic skin lesions/ plaques either with a yellowish or xanthochromic color.
The pharmacological treatment of LS is a challenge, in general, aimed at suppressing inflammation and collagen alterations, as well as inhibiting events involved in the autoimmune process. Intense Pulsed Light (IPL) is also reported in the literature as a therapeutic resource in LS and should be considered.
The mechanism of action of LS treatment with IPL is not yet fully understood but a common theory is that the photobiomodulation, where light is converted into chemical energy, modulates cellular activity in the collagen and melanin synthesis, reduces inflammation and has immunomodulatory effect on lesional skin, restoring its function.
The IPL-Sq® handpiece, compatible with the ETHEREA-MX® and ZYE® platforms, has a square pulse (Square-Wave Pulse®), a large pulse time variation (5-100 ms) and filters from 400 to 695 nm allowing for a wide variety of treatments.